Published in Clin Mol Hepatol on September 30, 2015
Early liver transplantation for severe alcoholic hepatitis. N Engl J Med (2011) 8.50
Alcoholic liver disease. Hepatology (2010) 5.04
Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med (2015) 3.47
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology (2014) 3.28
Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet (2009) 3.24
MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology (2005) 2.99
Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial. J Hepatol (2014) 2.65
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med (2011) 2.44
Utility of a new model to diagnose an alcohol basis for steatohepatitis. Gastroenterology (2006) 2.25
The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology (2007) 2.20
The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis. J Hepatol (2011) 2.05
A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology (2014) 2.00
Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA (2013) 1.94
The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis. Clin Gastroenterol Hepatol (2013) 1.67
Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis. Gastroenterology (2015) 1.63
Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study. J Hepatol (2015) 1.58
Gut-liver axis in alcoholic liver disease. Gastroenterology (2014) 1.42
Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. Hepatology (2015) 1.32
Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. Hepatology (2003) 1.26
Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. J Hepatol (2007) 1.26
Alcoholic hepatitis: current challenges and future directions. Clin Gastroenterol Hepatol (2013) 1.25
Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis. Gastroenterology (2014) 1.18
Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database. Hepatology (2012) 1.15
Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology (2010) 1.14
Trends in the management and burden of alcoholic liver disease. J Hepatol (2015) 1.05
Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis. Gastroenterology (2015) 0.95
The place of liver transplantation in the treatment of severe alcoholic hepatitis. J Hepatol (2010) 0.93
Trends in Alcoholic Hepatitis-related Hospitalizations, Financial Burden, and Mortality in the United States. J Clin Gastroenterol (2015) 0.93
Invasive aspergillosis in patients with severe alcoholic hepatitis. J Hepatol (2013) 0.91
Long-term outcome in patients with severe alcoholic hepatitis can be reliably determined using an in vitro measure of steroid sensitivity. Hepatology (2014) 0.82
Management practices of hepatitis C virus infected alcoholic hepatitis patients: A survey of physicians. World J Gastrointest Pharmacol Ther (2013) 0.81
Utilization of baclofen in maintenance of alcohol abstinence in patients with alcohol dependence and alcoholic hepatitis with or without cirrhosis. Alcohol Alcohol (2014) 0.79
Interplay of interleukin-22 and its binding protein in controlling liver scarring. Hepatology (2015) 0.77